Russia (bbabo.net), - Immediately, two anti-covid news came from cities near Moscow. In Dubna, the production of test systems for the detection of infectious diseases, including the coronavirus strain "omicron", has begun, and in Solnechnogorsk, the drug "Nobasit" will be produced, which successfully treats COVID-19.
The launch of test production was announced by one of the residents of the special economic zone "Dubna" - the company "White Service". This investor came to the SEZ last summer, and it took him only a few months to start production. The new production is based on a proven component base, which has shown itself well in identifying all strains of COVID-19. The test systems have successfully passed clinical trials at the National Research Center for Epidemiology and Microbiology named after N.F. Gamaleya and have the entire set of permits from Roszdravnadzor. According to the developers, the technologies used in production endow their tests with the ability to distinguish infection from the first day, and it takes no more than 15 minutes to get the result.
And in the Esipovo industrial park, which is located in the Solnechnogorsk district, the construction of a plant for the production of medicines, including the drug Nobazit, which is widely in demand during the pandemic, will start. This medicine several times reduces the likelihood of pulmonary insufficiency with COVID-19 and, in addition, is considered an affordable and effective tool for preventing the severe consequences of SARS and influenza.
Initially, the investor, the Aveksima company, planned to develop an area of 20 hectares by building a plant for 1,000 jobs. But since the end of the pandemic is not yet in sight, they decided to expand the project. "At the end of last year, Aveksima and the Moscow Region Development Corporation signed an additional agreement to increase the area of the site to 33 hectares. The number of jobs at the enterprise will also increase - up to 1,450 people. And antitumor drugs and antibiotics will also appear in the range of products manufactured by the plant," - notes Zinoviev.
Vladimir Slipenkin, General Director of the Moscow Region Development Corporation, adds: “During a pandemic, when new strains of coronavirus are rapidly emerging, it is very important to effectively develop research activities in the field of medicine, develop new drugs and expand pharmaceutical production. It is gratifying that Esipovo "Enterprises that introduce high-tech pharmaceutical technologies and create highly skilled jobs are being localized."
Moscow Region tests distinguish well all strains of coronavirus, including Omicron
As specified in the Corporation for the Development of the Moscow Region, the first batch of "Nobasit" produced near Moscow should appear on sale in 2024.
Back to news » Back to news » Back to news » Back to news » Back to news » Back to news » Back to news » Back to news » Back to news » Back to news » Back to news » Back to news »
We are monitoring the situation
Over the past day, 7,056 new patients with COVID-19 have been recorded in the Moscow region. "Omicron" is spreading rapidly, the burden on healthcare has already increased seven times, according to the regional Ministry of Health. Therefore, the authorities have taken additional measures that will minimize the waiting time for a doctor and diagnosis for residents with signs of colds.Starting today, January 24, polyclinics in the region will work according to the new rules. All patients with symptoms of acute respiratory viral infections and influenza and a temperature of less than 38 degrees can independently contact a therapist in their clinic without an appointment. Separate routing around the medical facility will be organized for them so that the sick do not intersect with healthy visitors. On the same day, the doctor will receive all those who apply and take a test for COVID-19 from everyone.
This will help to avoid situations when citizens with mild symptoms of the disease wait for a doctor at home for several days, worrying about the date on which the sick leave will be opened for them.
Scheduled examinations of narrow specialists in polyclinics will be limited for some time - all forces are thrown into the fight against "omicron". However, if the emergency assistance of such a specialist is needed, the therapist will refer the patient for an appointment, according to the Ministry of Health.
The department reminds that all polyclinics of the region have been transferred to a daily operating mode from 8.00 to 20.00. And they advise residents not to neglect the precautionary measures. Take antiviral agents in prophylactic doses, forget about personal protective equipment and once again avoid visiting crowded places without the need.
bbabo.Net